LON:BXP - BEXIMCO PHARMAC/S GDR REGS Stock Price, Price Target & More Sign in or create an account to add this stock to your watchlist. Get Started GBX 48.50 +1.00 (+2.11 %) (As of 07/18/2018 06:51 AM ET)Previous CloseGBX 47.50Today's RangeGBX 48.50 - GBX 48.5052-Week RangeGBX 50.38 - GBX 71.75Volume2,061 shsAverage Volume35,555 shsMarket Capitalization£40.76 billionP/E RatioN/ADividend Yield0.85%BetaN/A Company ProfileAnalyst RatingsHeadlinesChart Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulation products and active pharmaceutical ingredients. The company offers allergic disorder, analgesic and antipyretic, anti-infective, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, muscloskeletal, oncology, respiratory, skin care, vitamin and mineral supplement, and other products. It also provides contract manufacturing services. The company offers its products in approximately 50 countries. Beximco Pharmaceuticals Limited was founded in 1976 and is headquartered in Dhaka, Bangladesh. Receive BXP News and Ratings via Email Sign-up to receive the latest news and ratings for BXP and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange LON Industry Drug Manufacturers - Major Sub-IndustryN/A SectorMedical SymbolLON:BXP CUSIPN/A Webwww.beximco-pharma.com Phone+880-2-58611001 Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / CashN/A Book ValueN/A Price / BookN/A Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/A Miscellaneous EmployeesN/A Outstanding Shares405,560,000Market Cap£40,760.00 BEXIMCO PHARMAC/S GDR REGS (LON:BXP) Frequently Asked Questions What is BEXIMCO PHARMAC/S GDR REGS's stock symbol? BEXIMCO PHARMAC/S GDR REGS trades on the London Stock Exchange (LON) under the ticker symbol "BXP." What price target have analysts set for BXP? 2 analysts have issued 1 year price objectives for BEXIMCO PHARMAC/S GDR REGS's stock. Their forecasts range from GBX 75 to GBX 84. On average, they anticipate BEXIMCO PHARMAC/S GDR REGS's stock price to reach GBX 79.50 in the next year. This suggests a possible upside of 63.9% from the stock's current price. View Analyst Ratings for BEXIMCO PHARMAC/S GDR REGS. What is the consensus analysts' recommendation for BEXIMCO PHARMAC/S GDR REGS? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for BEXIMCO PHARMAC/S GDR REGS in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." Who are some of BEXIMCO PHARMAC/S GDR REGS's key competitors? Some companies that are related to BEXIMCO PHARMAC/S GDR REGS include Sanofi (SAN), Bayer (BAYN), GlaxoSmithKline (GSK), AstraZeneca (AZN), OTSUKA HOLDINGS/ADR (OTSKY), Hutchison China MediTech (HCM), Dechra Pharmaceuticals (DPH), Mayne Pharma Group (MYX), Vectura Group (VEC), Eco Animal Health Group (EAH), Trilogy International Partners (TRL), Allergy Therapeutics (AGY), Sinclair Pharma (SPH), Pharmaxis (PXS) and NanoViricides (NNVC). Who are BEXIMCO PHARMAC/S GDR REGS's key executives? BEXIMCO PHARMAC/S GDR REGS's management team includes the folowing people: Mr. Nazmul Hassan MP, MD & DirectorMr. Ali Nawaz, Chief Fin. OfficerMr. Rabbur Reza, Chief Operating OfficerMr. Jamal Ahmed Choudhury, Exec. Director of Accounts & Fin.Mr. M. A. Arshad Bhuiyan, Deputy Gen. Mang. of HR Has BEXIMCO PHARMAC/S GDR REGS been receiving favorable news coverage? News coverage about BXP stock has trended positive this week, Accern Sentiment Analysis reports. Accern identifies positive and negative news coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. BEXIMCO PHARMAC/S GDR REGS earned a media sentiment score of 0.46 on Accern's scale. They also gave press coverage about the company an impact score of 46.22 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the immediate future. How do I buy shares of BEXIMCO PHARMAC/S GDR REGS? Shares of BXP and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is BEXIMCO PHARMAC/S GDR REGS's stock price today? One share of BXP stock can currently be purchased for approximately GBX 48.50. How big of a company is BEXIMCO PHARMAC/S GDR REGS? BEXIMCO PHARMAC/S GDR REGS has a market capitalization of £40.76 billion. How can I contact BEXIMCO PHARMAC/S GDR REGS? BEXIMCO PHARMAC/S GDR REGS's mailing address is 19 Dhanmondi R/A, Road No. 7, DHAKA, 1205, Bangladesh. The company can be reached via phone at +880-2-58611001. MarketBeat Community Rating for BEXIMCO PHARMAC/S GDR REGS (LON BXP)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 67 (Vote Outperform)Underperform Votes: 74 (Vote Underperform)Total Votes: 141MarketBeat's community ratings are surveys of what our community members think about BEXIMCO PHARMAC/S GDR REGS and other stocks. Vote "Outperform" if you believe BXP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BXP will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 7/18/2018 by MarketBeat.com StaffFeatured Article: What does earnings per share mean?